nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—Dinoprost Tromethamine—HPGDS—liver cancer	0.0505	1	CrCbGaD
Tafluprost—PTGS2—S1P1 pathway—KDR—liver cancer	0.00943	0.00993	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—liver cancer	0.00933	0.00983	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—EFNB2—liver cancer	0.00917	0.00966	CbGpPWpGaD
Tafluprost—PTGS2—Arachidonic acid metabolism—HPGDS—liver cancer	0.00873	0.0092	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR4—liver cancer	0.00863	0.00909	CbGpPWpGaD
Tafluprost—PTGS2—Calcium signaling in the CD4+ TCR pathway—CSF2—liver cancer	0.00825	0.00869	CbGpPWpGaD
Tafluprost—PTGS2—Overview of nanoparticle effects—PIK3CD—liver cancer	0.00764	0.00804	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR4—liver cancer	0.0074	0.00779	CbGpPWpGaD
Tafluprost—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—liver cancer	0.00682	0.00719	CbGpPWpGaD
Tafluprost—PTGS2—Arachidonic acid metabolism—GGT1—liver cancer	0.00653	0.00688	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—PRKCE—liver cancer	0.00643	0.00677	CbGpPWpGaD
Tafluprost—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—liver cancer	0.00596	0.00628	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—GPX3—liver cancer	0.00591	0.00622	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCE—liver cancer	0.00575	0.00606	CbGpPWpGaD
Tafluprost—PTGS2—Signaling mediated by p38-alpha and p38-beta—MAPK14—liver cancer	0.00575	0.00605	CbGpPWpGaD
Tafluprost—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—liver cancer	0.00564	0.00594	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CCR4—liver cancer	0.00563	0.00593	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—liver cancer	0.00547	0.00576	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—liver cancer	0.00533	0.00562	CbGpPWpGaD
Tafluprost—PTGS2—S1P1 pathway—VEGFA—liver cancer	0.00519	0.00547	CbGpPWpGaD
Tafluprost—PTGS2—Arachidonic acid metabolism—CYP1A1—liver cancer	0.00511	0.00539	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—ESR1—liver cancer	0.00453	0.00477	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—F2—liver cancer	0.00446	0.0047	CbGpPWpGaD
Tafluprost—PTGS2—Overview of nanoparticle effects—TNF—liver cancer	0.00445	0.00469	CbGpPWpGaD
Tafluprost—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—liver cancer	0.00436	0.00459	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CHN2—liver cancer	0.00429	0.00452	CbGpPWpGaD
Tafluprost—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—liver cancer	0.00424	0.00447	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—GGT1—liver cancer	0.00416	0.00438	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—liver cancer	0.00399	0.00421	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IFT88—liver cancer	0.00392	0.00413	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.00392	0.00413	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—liver cancer	0.00387	0.00407	CbGpPWpGaD
Tafluprost—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—liver cancer	0.00365	0.00384	CbGpPWpGaD
Tafluprost—PTGS2—Overview of nanoparticle effects—IL6—liver cancer	0.00359	0.00378	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—GSTM1—liver cancer	0.00356	0.00375	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.00336	0.00354	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—TRIO—liver cancer	0.00332	0.0035	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CCR4—liver cancer	0.00318	0.00335	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	0.00308	0.00324	CbGpPWpGaD
Tafluprost—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—liver cancer	0.00306	0.00322	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.00305	0.00321	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—MTHFR—liver cancer	0.00303	0.00319	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—TRIO—liver cancer	0.00302	0.00318	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00301	0.00317	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—liver cancer	0.003	0.00316	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.00299	0.00315	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.00296	0.00311	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCR4—liver cancer	0.00289	0.00304	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.00284	0.00299	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—liver cancer	0.00282	0.00297	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—liver cancer	0.00282	0.00297	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—liver cancer	0.00274	0.00289	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—F2—liver cancer	0.00266	0.0028	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APCS—liver cancer	0.00264	0.00278	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.00256	0.0027	CbGpPWpGaD
Tafluprost—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—liver cancer	0.00241	0.00254	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SHC3—liver cancer	0.0024	0.00253	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.00236	0.00248	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—F2—liver cancer	0.00225	0.00237	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—SERPINE1—liver cancer	0.00222	0.00233	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—ALB—liver cancer	0.00221	0.00233	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.00219	0.00231	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.00218	0.00229	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—CDKN2A—liver cancer	0.00215	0.00226	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—liver cancer	0.00205	0.00216	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—PIK3CA—liver cancer	0.002	0.0021	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.00196	0.00207	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	0.00194	0.00205	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00194	0.00204	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—CDKN1B—liver cancer	0.0019	0.002	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00187	0.00197	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FST—liver cancer	0.00187	0.00197	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.00185	0.00195	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PRKCE—liver cancer	0.00183	0.00193	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—CCND1—liver cancer	0.00181	0.00191	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	0.00179	0.00188	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TRIO—liver cancer	0.00178	0.00188	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—CDKN1A—liver cancer	0.00176	0.00185	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCR4—liver cancer	0.00171	0.0018	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.00168	0.00177	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PRKCE—liver cancer	0.00166	0.00175	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.00165	0.00174	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CSF2—liver cancer	0.00162	0.00171	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.00158	0.00166	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.00148	0.00156	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CSF2—liver cancer	0.00147	0.00155	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—MYC—liver cancer	0.00146	0.00153	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.00145	0.00153	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CDKN1B—liver cancer	0.00145	0.00153	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00143	0.0015	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—UGDH—liver cancer	0.00142	0.0015	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CASP3—liver cancer	0.00142	0.0015	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL2—liver cancer	0.00142	0.00149	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CCND1—liver cancer	0.00138	0.00146	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.00137	0.00144	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ADAM17—liver cancer	0.00135	0.00142	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—KRAS—liver cancer	0.00134	0.00142	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MMP9—liver cancer	0.00134	0.00141	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—EPT1—liver cancer	0.00134	0.00141	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—TNF—liver cancer	0.00131	0.00138	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—F2—liver cancer	0.00127	0.00134	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PSMA4—liver cancer	0.00127	0.00134	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PSMD10—liver cancer	0.00127	0.00134	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—TAT—liver cancer	0.00127	0.00134	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00125	0.00131	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CG—liver cancer	0.00122	0.00128	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—F2—liver cancer	0.00116	0.00122	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—HRAS—liver cancer	0.00114	0.0012	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MYC—liver cancer	0.00111	0.00117	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TGFB1—liver cancer	0.00111	0.00117	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CG—liver cancer	0.00111	0.00116	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.00108	0.00113	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CD—liver cancer	0.00107	0.00113	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL6—liver cancer	0.00105	0.00111	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TNF—liver cancer	0.00103	0.00109	CbGpPWpGaD
Tafluprost—PTGS2—Disease—LTF—liver cancer	0.00103	0.00108	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000986	0.00104	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PRKCE—liver cancer	0.000983	0.00104	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CD—liver cancer	0.000972	0.00102	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000966	0.00102	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.00094	0.00099	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000938	0.000988	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000934	0.000984	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CB—liver cancer	0.000933	0.000983	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IGF2—liver cancer	0.000932	0.000981	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000931	0.000981	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TP53—liver cancer	0.000911	0.000959	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.00091	0.000958	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000888	0.000935	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CSF2—liver cancer	0.00087	0.000916	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—RAF1—liver cancer	0.000868	0.000914	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CPT1B—liver cancer	0.000862	0.000908	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GLUL—liver cancer	0.000862	0.000908	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—H2AFX—liver cancer	0.000857	0.000903	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—IL2—liver cancer	0.000857	0.000903	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CB—liver cancer	0.000847	0.000892	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL6—liver cancer	0.000834	0.000878	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NR1H4—liver cancer	0.000832	0.000876	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.00082	0.000863	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTA3—liver cancer	0.000818	0.000861	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ALDOB—liver cancer	0.000796	0.000838	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL2—liver cancer	0.000778	0.00082	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TERT—liver cancer	0.000775	0.000817	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000754	0.000794	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000752	0.000793	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTA4—liver cancer	0.000748	0.000788	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000731	0.00077	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTA2—liver cancer	0.000729	0.000767	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KDR—liver cancer	0.000709	0.000747	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAPK14—liver cancer	0.000704	0.000742	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTA1—liver cancer	0.000703	0.00074	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000703	0.00074	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000697	0.000734	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NAT2—liver cancer	0.000695	0.000732	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ESR1—liver cancer	0.000691	0.000728	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—F2—liver cancer	0.000683	0.000719	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000668	0.000704	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALDOB—liver cancer	0.000666	0.000702	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—APC—liver cancer	0.000653	0.000688	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CG—liver cancer	0.000653	0.000688	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.00064	0.000674	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CRABP1—liver cancer	0.000636	0.00067	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ADAM17—liver cancer	0.000629	0.000663	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000619	0.000652	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—BRAF—liver cancer	0.000614	0.000647	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PSMA4—liver cancer	0.000591	0.000623	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PSMD10—liver cancer	0.000591	0.000623	CbGpPWpGaD
Tafluprost—PTGS2—Disease—GOT2—liver cancer	0.000575	0.000606	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CD—liver cancer	0.000574	0.000605	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000572	0.000603	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CA—liver cancer	0.000569	0.000599	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SERPINE1—liver cancer	0.000568	0.000598	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—KRAS—liver cancer	0.000562	0.000592	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HPGDS—liver cancer	0.000556	0.000585	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000552	0.000582	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.000523	0.000551	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CA—liver cancer	0.000517	0.000544	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RAF1—liver cancer	0.000513	0.00054	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000503	0.00053	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MTOR—liver cancer	0.000501	0.000527	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CB—liver cancer	0.000501	0.000527	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000497	0.000523	CbGpPWpGaD
Tafluprost—PTGS2—Disease—GOT1—liver cancer	0.000497	0.000523	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PSMD10—liver cancer	0.000495	0.000522	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PSMA4—liver cancer	0.000495	0.000522	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GOT2—liver cancer	0.000482	0.000507	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HRAS—liver cancer	0.000478	0.000503	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CDKN1B—liver cancer	0.00047	0.000495	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—AKT1—liver cancer	0.000465	0.000489	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CASP3—liver cancer	0.00046	0.000485	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL2—liver cancer	0.00046	0.000484	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PRKCE—liver cancer	0.000458	0.000483	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6—liver cancer	0.000457	0.000482	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP2E1—liver cancer	0.000453	0.000477	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCND1—liver cancer	0.000448	0.000472	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—JUN—liver cancer	0.000447	0.000471	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CTNNB1—liver cancer	0.000444	0.000467	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000439	0.000462	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MMP9—liver cancer	0.000435	0.000458	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CDKN1A—liver cancer	0.000434	0.000457	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYCS—liver cancer	0.000424	0.000446	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAPK8—liver cancer	0.000423	0.000446	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AKT1—liver cancer	0.000422	0.000444	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GOT1—liver cancer	0.000416	0.000438	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GGT1—liver cancer	0.000416	0.000438	CbGpPWpGaD
Tafluprost—PTGS2—Disease—H2AFX—liver cancer	0.0004	0.000421	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—VEGFA—liver cancer	0.000391	0.000411	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—STAT3—liver cancer	0.000387	0.000407	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTP1—liver cancer	0.000374	0.000394	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HMOX1—liver cancer	0.000368	0.000388	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MTHFR—liver cancer	0.000362	0.000382	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TERT—liver cancer	0.000361	0.000381	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MYC—liver cancer	0.000359	0.000379	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TGFB1—liver cancer	0.000359	0.000378	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTM1—liver cancer	0.000343	0.000362	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KRAS—liver cancer	0.000332	0.00035	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP1A1—liver cancer	0.000325	0.000343	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CA—liver cancer	0.000305	0.000321	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APC—liver cancer	0.000304	0.000321	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MTHFR—liver cancer	0.000303	0.00032	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPARA—liver cancer	0.000298	0.000314	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TP53—liver cancer	0.000295	0.000311	CbGpPWpGaD
Tafluprost—PTGS2—Disease—BRAF—liver cancer	0.000286	0.000301	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HRAS—liver cancer	0.000282	0.000297	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6—liver cancer	0.00027	0.000285	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CD—liver cancer	0.000268	0.000282	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000267	0.000282	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SERPINE1—liver cancer	0.000265	0.000279	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CG—liver cancer	0.000255	0.000269	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AKT1—liver cancer	0.000249	0.000263	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPARG—liver cancer	0.000246	0.000259	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RAF1—liver cancer	0.000239	0.000252	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MTOR—liver cancer	0.000233	0.000246	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CB—liver cancer	0.000233	0.000246	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CD—liver cancer	0.000224	0.000236	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALB—liver cancer	0.000221	0.000233	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CDKN1B—liver cancer	0.000219	0.000231	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CTNNB1—liver cancer	0.000207	0.000218	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CDKN1A—liver cancer	0.000202	0.000213	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CB—liver cancer	0.000195	0.000206	CbGpPWpGaD
Tafluprost—PTGS2—Disease—STAT3—liver cancer	0.00018	0.00019	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MYC—liver cancer	0.000168	0.000176	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TGFB1—liver cancer	0.000167	0.000176	CbGpPWpGaD
Tafluprost—PTGS2—Disease—KRAS—liver cancer	0.000155	0.000163	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CA—liver cancer	0.000142	0.00015	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HRAS—liver cancer	0.000132	0.000139	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6—liver cancer	0.000126	0.000133	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CA—liver cancer	0.000119	0.000125	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKT1—liver cancer	0.000116	0.000122	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AKT1—liver cancer	9.73e-05	0.000102	CbGpPWpGaD
